title: Endocrine response to acute resistance exercise in obese versus lean physically active men.
abstract: OBJECTIVE
  Resistance exercise induces a host of endocrine responses that potentiate its effects on body composition and metabolism. Excess adiposity negatively affects some hormonal responses to exercise in sedentary men. This study compared the resistance exercise (RE)-associated growth hormone (GH), insulin-like growth factor-1 (IGF-1), and testosterone responses in lean vs. obese physically active men.
  
  
  METHODS
  Ten healthy physically active obese males (body fat  % 36.2 ± 4.03, age 24.6 ± 3.7 years, mass 104.5 ± 15.5 kg, height 178.8 ± 6.0 cm) were compared to ten lean counterparts (body fat  % 12.7 ± 2.9, age 24.6 ± 3.7 years, mass 77.1 ± 6.4 kg, height 177.2 ± 4.8 cm). The muscular endurance RE protocol consisted of six sets of ten repetitions per leg of stepping onto an elevated platform (20 % of participant's height) while wearing a weighted-vest (50 % of participant's lean mass). Pre-, immediately post-exercise (IP), and three more blood samples were collected during the one-hour recovery.
  
  
  RESULTS
  When accounting for baseline differences there were no group by time interactions for GH (p = 0.33); or LH (p = 0.52). Lean presented a trend towards significance for higher IGF-1 IP (p = 0.08) than obese. Testosterone IP was similar in obese and lean, but lower in obese than lean at 30 min into recovery (p < 0.01). AUC were lower in obese than lean for all hormones (p < 0.05 for all).
  
  
  CONCLUSIONS
  These findings suggest that excess adiposity does not appear to negatively affect the immediate GH and T responses to RE in active males; but possibly negatively affects IGF-1. However, the baseline and integrated concentrations during recovery appear negatively affected by excess adiposity.
authors: Department of Kinesiology, California State University, 800 N. State College Blvd., Fullerton, CA, 92834, USA, drubin@fullerton.edu.
authors: Daniela A
authors: DA
authors: Rubin
authors: Hoang N
authors: HN
authors: Pham
authors: Eric S
authors: ES
authors: Adams
authors: Andrew R
authors: AR
authors: Tutor
authors: Anthony C
authors: AC
authors: Hackney
authors: Jared W
authors: JW
authors: Coburn
authors: Daniel A
authors: DA
authors: Judelson
mesh_terms: D000328:Adult; D001794:Blood Pressure; D016022:Case-Control Studies; D019382:Human Growth Hormone / Q000097:blood*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008297:Male; D009765:Obesity / Q000097:blood / Q000503:physiopathology*; D055070:Resistance Training; D013739:Testosterone / Q000097:blood*
chemical_list: D019382:Human Growth Hormone; D013739:Testosterone; D007334:Insulin-Like Growth Factor I
references: Nutr Metab Cardiovasc Dis. 2009 Dec;19(10):713-9
references: 19346116
references: Andrology. 2014 Jul;2(4):588-95
references: 24782426
references: J Obes. 2011;2011:null
references: 20847892
references: Clin Endocrinol (Oxf). 2013 Apr;78(4):593-9
references: 22970699
references: Eur J Appl Physiol. 2009 Nov;107(4):397-409
references: 19649649
references: Int J Sports Med. 2002 Jul;23(5):307-12
references: 12165880
references: Cancer Causes Control. 2012 Dec;23(12):1881-91
references: 23053790
references: J Appl Physiol (1985). 2004 Feb;96(2):531-9
references: 14514704
references: Pediatr Exerc Sci. 2014 Nov;26(4):444-54
references: 25372379
references: Med Sci Sports Exerc. 2009 Jun;41(6):1261-70
references: 19461539
references: Med Sci Sports Exerc. 2005 Mar;37(3):395-403
references: 15741837
references: Med Sci Sports Exerc. 2011 Jul;43(7):1334-59
references: 21694556
references: J Androl. 2008 May-Jun;29(3):251-9
references: 18222914
references: Med Sci Sports Exerc. 2006 Jul;38(7):1288-96
references: 16826026
references: J Endocrinol Invest. 2012 Dec;35(11):947-50
references: 23310924
references: Endocrinology. 2013 Apr;154(4):1501-12
references: 23439698
references: Med Sci Sports Exerc. 2013 Nov;45(11):2044-51
references: 24136137
references: J Clin Endocrinol Metab. 2008 Dec;93(12):4711-20
references: 18782875
references: Endocrine. 2012 Feb;41(1):144-51
references: 21983797
references: Eur J Appl Physiol. 2000 May;82(1-2):121-8
references: 10879453
references: Int J Obes Relat Metab Disord. 1997 May;21(5):355-9
references: 9152736
references: J Appl Physiol (1985). 2001 Sep;91(3):1251-8
references: 11509523
references: J Appl Physiol (1985). 2011 Aug;111(2):465-72
references: 21636569
references: Clin Endocrinol (Oxf). 2013 Mar;78(3):373-8
references: 22469460
references: J Clin Endocrinol Metab. 2001 Jan;86(1):200-6
references: 11232001
references: Med Sci Sports Exerc. 2013 Mar;45(3):420-8
references: 23034644
references: Sports Med. 2012 May 1;42(5):415-31
references: 22455310
references: J Appl Physiol (1985). 2009 May;106(5):1529-37
references: 19265063
references: Sports Med. 2005;35(5):393-412
references: 15896089
references: J Clin Endocrinol Metab. 1997 Mar;82(3):727-34
references: 9062473
references: J Biol Chem. 1999 May 7;274(19):13434-42
references: 10224108
references: Reprod Health. 2011 Aug 17;8:24
references: 21849026
references: Eur J Appl Physiol. 2003 Aug;89(6):555-63
references: 12734759
references: Eur J Appl Physiol Occup Physiol. 1998 Apr;77(5):413-20
references: 9562291
references: J Appl Physiol (1985). 1999 Sep;87(3):982-92
references: 10484567
references: Clin Endocrinol (Oxf). 2010 Oct;73(4):491-6
references: 20550528
references: Metabolism. 2013 Nov;62(11):1543-52
references: 23932846
references: Sports Med. 2005;35(4):339-61
references: 15831061